Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AISHA SHAFIQ

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1679802854
CMS profile
752981
Location
VALENCIA, CA

General Payments · PY2018–2024

$909.89

  • Reported across 53 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$628.18

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $628.18 38

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $215.57 19
ABBVIE INC. $109.01 5
SHIELD THERAPEUTICS INC $59.64 2
Lilly USA, LLC $44.13 2
PFIZER INC. $34.82 2
Hologic Sales and Service, LLC $25.68 1
Acerta Pharma LLC $23.15 1
Exact Sciences Corporation $21.82 1
Novo Nordisk AS $20.89 1
COLOPLAST CORP $20.44 1
Abbott Laboratories $19.71 1
GlaxoSmithKline, LLC. $19.25 1
Phathom Pharmaceuticals, Inc. $14.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $160.41 9
PY2021 $12.38 1
PY2022 $22.99 1
PY2023 $85.93 4
PY2024 $628.18 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $19.71 12/26/2024 Food and Beverage Undisputed 01/23/2026 1125191737 CMS
ABBVIE INC. $18.37 07/22/2024 Food and Beverage Undisputed 01/23/2026 1106062114 CMS
ABBVIE INC. $33.81 07/23/2024 Food and Beverage Undisputed 01/23/2026 1106062116 CMS
ABBVIE INC. $15.05 09/05/2024 Food and Beverage Undisputed 01/23/2026 1106062118 CMS
ABBVIE INC. $23.10 10/22/2024 Food and Beverage Undisputed 01/23/2026 1106062120 CMS
ABBVIE INC. $18.68 11/08/2024 Food and Beverage Undisputed 01/23/2026 1106062122 CMS
Amgen Inc. $12.15 07/09/2024 Food and Beverage Undisputed 01/23/2026 1117379714 CMS
Amgen Inc. $9.10 07/16/2024 Food and Beverage Undisputed 01/23/2026 1117379716 CMS
Amgen Inc. $8.94 07/23/2024 Food and Beverage Undisputed 01/23/2026 1117379718 CMS
Amgen Inc. $11.26 07/30/2024 Food and Beverage Undisputed 01/23/2026 1117379720 CMS
Amgen Inc. $10.04 08/06/2024 Food and Beverage Undisputed 01/23/2026 1117379722 CMS
Amgen Inc. $11.95 08/13/2024 Food and Beverage Undisputed 01/23/2026 1117379724 CMS
Amgen Inc. $12.10 08/20/2024 Food and Beverage Undisputed 01/23/2026 1111702820 CMS
Amgen Inc. $22.70 08/22/2024 Food and Beverage Undisputed 01/23/2026 1111702818 CMS
Amgen Inc. $9.98 08/27/2024 Food and Beverage Undisputed 01/23/2026 1117379730 CMS
Amgen Inc. $11.58 09/03/2024 Food and Beverage Undisputed 01/23/2026 1117379726 CMS
Amgen Inc. $14.30 09/10/2024 Food and Beverage Undisputed 01/23/2026 1117379728 CMS
Amgen Inc. $14.22 09/17/2024 Food and Beverage Undisputed 01/23/2026 1117379732 CMS
Amgen Inc. $9.39 09/24/2024 Food and Beverage Undisputed 01/23/2026 1117379734 CMS
Amgen Inc. $9.00 10/15/2024 Food and Beverage Undisputed 01/23/2026 1117379736 CMS
Amgen Inc. $8.11 11/12/2024 Food and Beverage Undisputed 01/23/2026 1117379738 CMS
Amgen Inc. $9.01 11/26/2024 Food and Beverage Undisputed 01/23/2026 1117379740 CMS
Amgen Inc. $11.62 12/03/2024 Food and Beverage Undisputed 01/23/2026 1117379742 CMS
Amgen Inc. $8.09 12/10/2024 Food and Beverage Undisputed 01/23/2026 1117379744 CMS
Amgen Inc. $12.03 12/17/2024 Food and Beverage Undisputed 01/23/2026 1117379746 CMS
AstraZeneca Pharmaceuticals LP $23.15 07/29/2024 Food and Beverage Undisputed 01/23/2026 1104681071 CMS
COLOPLAST CORP $20.44 10/06/2024 Food and Beverage Undisputed 01/23/2026 1117450570 CMS
Exact Sciences Corporation $21.82 12/20/2024 Food and Beverage Undisputed 01/23/2026 1114887943 CMS
GlaxoSmithKline, LLC. $19.25 09/03/2024 Food and Beverage Undisputed 01/23/2026 1116580461 CMS
Hologic Sales and Service, LLC $25.68 08/15/2024 Food and Beverage Undisputed 01/23/2026 1084912652 CMS
Lilly USA, LLC $18.91 07/22/2024 Food and Beverage Undisputed 01/23/2026 1136011125 CMS
Lilly USA, LLC $25.22 10/04/2024 Food and Beverage Undisputed 01/23/2026 1136013572 CMS
Novo Nordisk Inc $20.89 08/27/2024 Food and Beverage Undisputed 01/23/2026 1096801638 CMS
PFIZER INC. $16.66 09/03/2024 Food and Beverage Undisputed 01/23/2026 1131933384 CMS
PFIZER INC. $18.16 09/26/2024 Food and Beverage Undisputed 01/23/2026 1131938711 CMS
Phathom Pharmaceuticals, Inc. $14.07 12/10/2024 Food and Beverage Undisputed 01/23/2026 1151123554 CMS
SHIELD THERAPEUTICS INC $34.38 08/06/2024 Food and Beverage Undisputed 01/23/2026 1150140838 CMS
SHIELD THERAPEUTICS INC $25.26 11/18/2024 Food and Beverage Undisputed 01/23/2026 1150154634 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.